Visual Abstract: Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 16, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1641?guestAccessKey=27101ae2-0299-4636-ae46-9e6c928e13e1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061622   Visual Abstract…

Visual Abstract: Efficacy of Pegasparaginase-Based Chemotherapy Regimen vs L-asparaginase–Based Regimen for Extranodal Natural Killer/T-Cell Lymphoma

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 16, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1968?guestAccessKey=e677efdb-e05c-46f6-9c45-8250fba74408&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061622   Visual Abstract…

Assessing Risk of Maternal Death in Pregnancies Complicated by Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 16, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1795?guestAccessKey=53666fe6-8c61-4ef6-8aa1-925d724bbda0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061622   About The Study: Researchers examined nationwide trends and characteristics…

JAMAONCO_OF:06092022

Risk Factors, Racial, Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1628?guestAccessKey=f59cfb53-9e1c-4d40-8d10-0d77617ef26c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060922

Assessment of Compliance With Centers for Medicare & Medicaid Services Price Transparency Final Rule

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1783?guestAccessKey=ed7608dc-a4c6-4f38-b178-fbec153a9283&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060922

JAMAONCO_OF:06022022

JAMAONCO_OF:05262022

Visual Abstract: Effect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast Size

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 26, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1479?guestAccessKey=b74760fc-69e3-4e2a-83f2-8d34a94ca3b3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=052622   Visual Abstract…

JAMAONCO_OF:05242022

JAMAONCO_OF:05192022

Change in Cancer Death Rates Among Black Individuals in US

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 19, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1472?guestAccessKey=4f8298ee-74af-4722-870e-e774477e130c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051922   About The Study: Researchers found in this cross-sectional study…

JAMAONCO_OF:05122022

Visual Abstract: Efficacy of Vistusertib With Anastrozole in Recurrent or Metastatic Endometrial Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 12, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1047?guestAccessKey=7ceee02b-5633-46ea-8090-de65d98f5d50&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051222   Visual Abstract Authors: Pierre…

Visual Abstract: Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer, Brain Metastases

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 12, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0514?guestAccessKey=d16b2127-1557-410e-9965-0bfac3675cb4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051222   Visual Abstract Authors: Debu…

JAMAONCO_OF:05052022

Racial, Ethnic Differences in Uterine Cancer Mortality Rates

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 5, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0009?guestAccessKey=bc521263-d45e-4eb6-8531-4b0b890fd93e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050522   About The Study: This study of 208,000 women showed…

Age at Initiation of Endoscopy, Colorectal Cancer Risk Among Women

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 5, 2022 Media advisory: The full study and editorial are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0883?guestAccessKey=8acc231b-cf2a-4115-ae46-e34a7f3d6497&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050522   About The Study: Compared with no endoscopy,…

JAMAONCO_OF:04282022

JAMAONCO_ADHOC:04222022

Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1467?guestAccessKey=a314a6bb-e264-4ade-86c3-0e104b8f74f9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042222

JAMAONCO_OF:04212022

Durability of Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0752?guestAccessKey=bed65c33-3051-450a-9874-e6858923afd2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042122

JAMAONCO_OF:04142022

JAMAONCO_ADHOC:04082022

Breakthrough SARS-CoV-2 Infections, Hospitalizations, Mortality in Vaccinated Patients With Cancer

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1096?guestAccessKey=da1de153-897a-41d6-80f6-14ae617e331a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040822

JAMAONCO_OF:04072022

Association of Medicaid Expansion With Mortality Disparity by Race, Ethnicity Among Patients With De Novo Stage IV Breast Cancer

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0159?guestAccessKey=acc01b6e-19ef-42f0-863a-7fcbda037aa6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040722

Association of Pandemic With Rates of Prostate Cancer Biopsies, Diagnoses in Black vs White US Veterans

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 7, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0467?guestAccessKey=92f3e2d1-bd5c-46de-bd55-7c4bb72dcb11&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040722   What The Study Did: Prostate biopsy and prostate cancer…

JAMAONCO_OF:03312022

Visual Abstract: TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 31, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3547?guestAccessKey=8d9bd1e6-f049-42d7-afe3-9c8e25f2daa8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033122   Visual Abstract Authors: Robin…

Association of Patient-Reported Outcomes With Nonfatal Self-injury After New Cancer Diagnosis

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0203?guestAccessKey=00e63a17-6219-47bf-8c53-40a8bd9f6638&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033122

Association of Changes in Medicaid Dental Benefits With Oral Cavity Cancer Diagnosis

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0149?guestAccessKey=6a711b05-104d-497e-9fc0-b0f83e4f049d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033122

JAMAONCO_OF:03242022

Self-reported Transportation Barriers to Health Care Among US Cancer Survivors

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0143?guestAccessKey=5cf125ad-4c75-4c74-8fa2-7e2cc23d7191&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032422

Visual Abstract: Paclitaxel, Cisplatin, Capecitabine vs Cisplatin, Fluorouracil for Nasopharyngeal Carcinoma

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 24, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0122?guestAccessKey=0dbfee8b-21aa-4dba-9124-1cad55464019&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032422   Visual Abstract…

JAMAONCO_OF:03172022

Risk of Colorectal Cancer Associated With Lifetime Excess Weight

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 17, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0064?guestAccessKey=f7acd72a-cef3-4048-b6f5-c79e1a5df966&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031722   What The Study Did: A greater number…

JAMAONCO_OF:03102022

Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0001?guestAccessKey=28a28d85-7f85-427c-b826-d89f6a8ecb4c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031022

JAMAONCO_OF:03032022

Factors Associated With Racial Disparity in Use of MRI Among Patients With Prostate Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 3, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.8116?guestAccessKey=de4ed44c-76d6-4a00-8162-6f8f7fc66096&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030322   What The Study Did: This study of…

Visual Abstract: Efficacy of HD201 vs Referent Trastuzumab in Patients With ERBB2-Positive Breast Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 3, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.8171?guestAccessKey=89bc130b-ab40-4ac6-88e6-4f65d4a27e5d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030322   Visual Abstract   Authors:…

JAMAONCO_OF:02242022

Visual Abstract: Palliative Radiation for Advanced Central Lung Tumors With Avoidance of the Esophagus

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 24, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7664?guestAccessKey=553a7379-6e75-4459-92c7-2ab0b6d97fea&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=022422   Visual Abstract…

Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7656?guestAccessKey=d9c22bbb-19ef-4c43-85f7-afc06c85febc&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021722

Visual Abstract: Capecitabine Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 17, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7366?guestAccessKey=1105ab84-3fa2-4968-8fc0-a0a004c7679a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021722   Visual Abstract…

JAMAONCO_OF:02172022

Visual Abstract: Autologous Dendritic Cell Immunotherapy Plus Chemotherapy in Metastatic Castration-Resistant Prostate Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 10, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7298?guestAccessKey=917838c5-d533-4d82-982c-5950df33843b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021022   Visual Abstract…

Visual Abstract: Effect of Symptom Monitoring Intervention for Patients Hospitalized With Advanced Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 10, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7643?guestAccessKey=37d42b48-589a-4d9b-82cc-956b70090d11&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021022   Visual Abstract   Authors:…

Association of HPV Vaccination, Incidence of Squamous Cell Carcinomas of Anus

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7652?guestAccessKey=c9a9b5b2-3c4c-405e-8021-ff8ccc302036&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021022

JAMAONCO_OF:02102022

JAMAONC_OF:02032022

JAMAONCO_OF:01272022

Geographic Disparities in Treatment of Curable Breast Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 27, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7337?guestAccessKey=7a16d9be-1ed0-42ab-bdbd-f456a1f31f88&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=012722   What The Study Did: The extent to which geographic…

JAMAONCO_OF:01202022

JAMAONCO_OF:01132022

Comparing Lung Cancer Screening Criteria for Racial Disparity in Eligibility

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 13, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6720?guestAccessKey=46113213-0bcc-4a03-a1c3-c4ea5e7383a2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011322   What The Study Did: The findings of…

JAMAONCO_ADHOC:01072022

SARS-CoV-2 Antibody Response to 2 or 3 Doses of BioNTech-Pfizer Vaccine in Patients With Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, JANUARY 7, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7777?guestAccessKey=64f57de0-65f5-4ccc-9c30-3abe123b5e3b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010722   What The Study Did: This study assessed the antibody…

Visual Abstract: Comparing Prophylactic Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 6, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6628?guestAccessKey=83a5b584-1fa5-48e4-82a9-28d957bdab6d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010622   Visual Abstract…

JAMAONCO_OF:01062022

Association of Sitting Time, Physical Activity With Cancer Survival

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 6, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6590?guestAccessKey=8b888a7b-1d4c-4ddc-94cb-2cd1ef14deb9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010622   What The Study Did: Researchers examined the associations of…

JAMAONCO_OF:12302021

Global Burden of Cancer, 2010 to 2019

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6987?guestAccessKey=de848f90-c09a-4361-9e2a-fe2c6562d9a2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=123021

JAMAONCO_OF:12232021

Visual Abstract: Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 23, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5981?guestAccessKey=f7d45c3d-a78d-4435-a89c-fb8eb9afa57d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122321   Visual Abstract   Authors:…

JAMAONCO_OF:12162021

JAMAONCO_OF:12092021

Diversity Among US Radiation, Medical Oncology Faculty

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 9, 2021 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6011?guestAccessKey=bb9a9220-1bbf-4ab2-96f9-b077e4984ff8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120921   What The Study Did: The results of…

JAMAONCO_OF:12022021

Effectiveness of COVID-19 Vaccination in Patients With Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 2, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5771?guestAccessKey=5fcd8b60-734c-4f79-8c52-139d4f069eac&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120221   What The Study Did: In this study of Veterans…

JAMAONCO_OF:11242021

Association Between Neighborhood Socioeconomic Inequality, Cervical Cancer Rates in New York City

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 24, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5779?guestAccessKey=875a08ed-82ac-42d8-befe-cd94de00c5cd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421   What The Study Did: In this population-based, cross-sectional study, researchers…

Eligibility of Black Women Under USPSTF Lung Cancer Screening Guidelines

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 24, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5790?guestAccessKey=988b5b64-a314-4333-ab42-05e8abd58fe2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421   What The Study Did: Researchers evaluated lung cancer screening eligibility…

Change in COVID-19 Mortality in Patients With Cancer During Pandemic

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 24, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6199?guestAccessKey=34bfddf6-8dcb-4cc5-b112-3792eda89ee4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421   What The Study Did: Evolving outcomes of COVID-19 in patients…

Outcomes of Screening for Prostate Cancer Among Men Who Use Statins

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5672?guestAccessKey=b34f9b8a-3809-4044-9079-510749446219&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421

JAMAONCO_OF:11232021

Assessing Response to Third Dose of SARS-CoV-2 BNT162b2 Vaccine in Patients With Solid Tumors

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6764?guestAccessKey=fa2f67e0-5398-479e-9c84-040b27818f41&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112321

JAMAONCO_OF:11182021

Telemedicine Use by Socioeconomic Status Among Patients With Newly Diagnosed Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 18, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5784?guestAccessKey=1bebfa23-1ea5-41a2-ab62-02ba8f55f0b5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111821   What The Study Did: Researchers found that among 16,000…

Visual Abstract: Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 18, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5445?guestAccessKey=9e2e2632-3143-4a5a-bff7-c19a1983fea5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111821   Visual Abstract   Authors:…

T-Cell Responses to SARS-CoV-2 Vaccines in Patients With B-Cell Depletion

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6030?guestAccessKey=d5abc9d4-27a3-4f58-bb04-59ee7ca15a4c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111821

JAMAONCO_11112021

Progress Against Cancer Deaths 50 Years After National Cancer Act Passed

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 11, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5668?guestAccessKey=fa22406b-0c85-463b-a38f-8a0bcd08f48f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111121   What The Study Did: This year is the 50th anniversary…

JAMAONCO_OF:11042021

JAMAONCO_OF:10282021

COVID-19 Death, Adverse Outcomes in Patients With, Without Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, OCTOBER 28, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5148?guestAccessKey=f51f92f4-9ae3-44f9-a1b1-659a3d763658&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=102821   What The Study Did: In this study of more than…

JAMAONCO_OF:10252021

Visual Abstract: Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 5:05 P.M. (ET), MONDAY, OCTOBER 25, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6036?guestAccessKey=fccdc560-4934-481d-954a-55b6eb373e97&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=102521   Visual Abstract   Authors: Chang-Ok…

JAMAONCO_OF:10212021

JAMAONCO_OF:10142021

Visual Abstract: Fulvestrant-Palbociclib vs. Letrozole-Palbociclib as Initial Therapy for Advanced Breast Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, OCTOBER 7, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.4301?guestAccessKey=4c8d31e5-75de-4219-ac23-dc4434ce706d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100721   Visual Abstract   Authors:…

JAMAONCO_OF:10072021

JAMAONCO_OF:09302021

Visual Abstract: Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 23, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3836?guestAccessKey=a7dff299-41e1-42da-b547-14b4adaf1c37&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092321   Visual Abstract   Authors:…

JAMAONCO_OF:09232021

JAMAONCO_OF:09162021

JAMAONCO_OF:09092021